512 Chapter 19 Toxic Substances and Environmental Justice
The Arduous Path to Managing Risk: Bisphenol A
One example of a potentially toxic substance that is working its way through the
government regulatory bureaucracy is Bisphenol A (BPA). The food industry uses
more than six billion pounds of BPA every year to make the resins that line food
cans and the polycarbonate plastics used to make baby bottles and many
other products. The Centers for Disease Control and Prevention (CDC) says that
95 percent of us carry measurable amounts of BPA in our blood.
In April 2008, the National Toxicology Program (NTP) at the National Institutes
of Health (NIH) expressed some concern that exposure to BPA during pregnancy
and childhood could impact the developing breast and prostate, hasten puberty,
and affect behavior in American children. Not long after those concerns were
expressed, the Canadian government moved to ban polycarbonate infant bottles
containing BPA, the most popular type of bottle on the market.
Despite the absence of any such ruling from the U.S. government, after the
Canadian move the U.S. market reacted. Major BPA manufacturers, including Playtex
(which makes bottles and cups) and Nalgene, which makes portable water bottles,
announced a shift to BPA-free products. Major retailers, including Walmart and Toys
“R” Us, announced they would quickly phase out BPA-containing baby bottles.
In January 2010, the U.S. Food and Drug Administration (FDA), which had
previously found BPA to be safe, announced, “On the basis of results from recent
studies using novel approaches to test for subtle effects, both the National
Toxicology Program at the National Institutes of Health and FDA have some con-
cern about the potential effects of BPA on the brain, behavior, and prostate gland
in fetuses, infants, and young children. In cooperation with the National Toxicology
Program, FDA’s National Center for Toxicological Research is carrying out in-depth
studies to answer key questions and clarify uncertainties about the risks of BPA.”
Interestingly, while the federal government continued to study the problem,
some states moved ahead with regulation. In April 2010, Maryland became the
fifth state to ban the use of BPA in children’s products, including baby bottles and
sippy cups. New York followed suit in July passing a bill that had unanimous
support in the legislature.
How this risk was handled in the United States is especially noteworthy in that
both the market and the states reacted well before federal regulation was in place.
Sources
: The National Institutes of Health web site: http://www.niehs.nih.gov/news/media/questions/
sya-bpa.cfm (accessed November 21, 2010); Food and Drug Administration web site: http://www.fda.
gov/newsevents/publichealthfocus/ucm064437.htm (accessed November, 21, 2010); Environmental
Working Group web site: http://www.ewg.org/reports/infantformula (accessed November, 21, 2010);
American Chemical Society web site: http://pubs.acs.org/cen/news/88/i04/8804notw2.html (accessed
November 21, 2010)
EXAMPLE
19.1
Market Allocations and Toxic Substances
Toxic substance contamination can arise in a variety of settings. In order to define
the efficient policy response, we must examine what responses would be forthcom-
ing in the normal operation of the market. Let’s look at three possible relationships